Pyrido(3,2-D)pyrimidines and pharmaceutical compositions useful for treating hepatitis C
申请人:Gilead Sciences, Inc.
公开号:US08232278B2
公开(公告)日:2012-07-31
Specifically substituted pyrido(3,2-d)pyrimidine derivatives having the structural formula (I) are useful for the treatment of hepatitis C.
具有结构式(I)的特定取代吡啶并(3,2-d)嘧啶衍生物对于治疗丙型肝炎是有用的。